282 related articles for article (PubMed ID: 8958217)
21. Membrane IgM, IgD, and IgG act as signal transmission molecules in a series of B lymphomas.
Mizuguchi J; Tsang W; Morrison SL; Beaven MA; Paul WE
J Immunol; 1986 Oct; 137(7):2162-7. PubMed ID: 3020122
[TBL] [Abstract][Full Text] [Related]
22. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
23. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
Hillion S; Garaud S; Devauchelle V; Bordron A; Berthou C; Youinou P; Jamin C
Immunology; 2007 Nov; 122(3):371-80. PubMed ID: 17608810
[TBL] [Abstract][Full Text] [Related]
25. FcgammaRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling.
Kono H; Kyogoku C; Suzuki T; Tsuchiya N; Honda H; Yamamoto K; Tokunaga K; Honda Z
Hum Mol Genet; 2005 Oct; 14(19):2881-92. PubMed ID: 16115811
[TBL] [Abstract][Full Text] [Related]
26. T-cell signaling abnormalities in human systemic lupus erythematosus.
Nambiar MP; Krishnan S; Tsokos GC
Methods Mol Med; 2004; 102():31-47. PubMed ID: 15286379
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of antigen receptor-dependent apoptosis of human B lymphoma cells probed with a panel of 27 monoclonal antibodies.
Grafton G; Goodall M; Gregory CD; Gordon J
Cell Immunol; 1997 Nov; 182(1):45-56. PubMed ID: 9427809
[TBL] [Abstract][Full Text] [Related]
28. Abnormal expression of various molecular forms and distribution of T cell receptor zeta chain in patients with systemic lupus erythematosus.
Nambiar MP; Enyedy EJ; Fisher CU; Krishnan S; Warke VG; Gilliland WR; Oglesby RJ; Tsokos GC
Arthritis Rheum; 2002 Jan; 46(1):163-74. PubMed ID: 11817588
[TBL] [Abstract][Full Text] [Related]
29. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
30. Enhanced propensity of T lymphocytes in patients with systemic lupus erythematosus to apoptosis in the presence of tumour necrosis factor alpha.
Habib HM; Taher TE; Isenberg DA; Mageed RA
Scand J Rheumatol; 2009; 38(2):112-20. PubMed ID: 19110660
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
32. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
33. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
[TBL] [Abstract][Full Text] [Related]
34. TCR zeta-chain abnormalities in human systemic lupus erythematosus.
Nambiar MP; Krishnan S; Warke VG; Tsokos GC
Methods Mol Med; 2004; 102():49-72. PubMed ID: 15286380
[TBL] [Abstract][Full Text] [Related]
35. Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus.
Anolik JH; Barnard J; Cappione A; Pugh-Bernard AE; Felgar RE; Looney RJ; Sanz I
Arthritis Rheum; 2004 Nov; 50(11):3580-90. PubMed ID: 15529346
[TBL] [Abstract][Full Text] [Related]
36. Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.
Kaneko U; Toyabe S; Hara M; Uchiyama M
Pediatr Allergy Immunol; 2006 Dec; 17(8):565-71. PubMed ID: 17121583
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls.
Jacobi AM; Goldenberg DM; Hiepe F; Radbruch A; Burmester GR; Dörner T
Ann Rheum Dis; 2008 Apr; 67(4):450-7. PubMed ID: 17673490
[TBL] [Abstract][Full Text] [Related]
38. Aberrant HS1 molecule in a patient with systemic lupus erythematosus.
Sawabe T; Horiuchi T; Koga R; Tsukamoto H; Kojima T; Harashima S; Kikuchi Y; Otsuka J; Mitoma H; Yoshizawa S; Niho Y; Watanabe T
Genes Immun; 2003 Mar; 4(2):122-31. PubMed ID: 12618860
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies to the translational suppressors T cell intracytoplasmic antigen 1 and T cell intracytoplasmic antigen 1-related protein in patients with rheumatic diseases: increased prevalence in systemic lupus erythematosus and systemic sclerosis and correlation with clinical features.
Jimenez-Boj E; Kedersha N; Tohidast-Akrad M; Karlhofer FM; Stummvoll G; Zimmermann C; Ulrich W; Guiducci S; Hoefler E; Aringer M; Schett G; Matucci-Cerinic M; Smolen JS; Steiner G
Arthritis Rheum; 2008 May; 58(5):1226-36. PubMed ID: 18438838
[TBL] [Abstract][Full Text] [Related]
40. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
